VATECH (www.vatech.co.kr), a global leader in dental imaging systems, today announced its Q2 2024 financial results through a preliminary disclosure. VATECH reported Q2 2024 revenue of KRW 101.98 billion, operating profit of KRW 16.84 billion, net profit of KRW 15.06 billion, and an operating margin of 16.5%.

Sales in North America increased by 11.7% compared to the same period last year, attributed to the addition of 'Henry Schein', the world's largest medical device distributor, to the U.S. distribution channel in 2023. During the same period, 3D X-ray sales grew by 13.9%, with the new product 'Green X 12' gaining widespread popularity and becoming the top-selling dental CT in VATECH's lineup. Export sales accounted for 89.8% of total Q2 revenue, with regional sales distribution as follows: North America 25.7%, Europe 29.6%, and Asia 28.9%.

Despite challenging market conditions such as decreased demand due to economic downturn and inflation, VATECH continues to invest in developing solutions for clinic digitization and expanding its international sales and service networks. The company believes that during economic hardships, customers tend to choose trusted brands. VATECH is also strengthening its bond with global customers and dealers by hosting events to introduce innovative future products.

For further details, please visit our website.